RAPT THERAPEUTICS INC. - COMMON STOCK
1.1800
24-يناير-25 15:45:00
15 متأخرة بدقائق
الأسهم
-0.0100
-0.84%
نطاق اليوم
1.1500 - 1.2450
ISIN
N/A
المصدر
NASDAQ
-
RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis
13 يونيو 2021 15:00:00 بحسب Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the UBS Global Healthcare Virtual Conference
20 مايو 2021 15:00:00 بحسب Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports First Quarter 2021 Financial Results
11 مايو 2021 07:00:02 بحسب Nasdaq GlobeNewswire
-
RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dermatitis
22 مارس 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results
11 مارس 2021 07:00:02 بحسب Nasdaq GlobeNewswire
-
10 مارس 2021 15:30:00 بحسب Nasdaq GlobeNewswire
-
RAPT Therapeutics to Participate in Two Investor Conferences in March
03 مارس 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
19 فبراير 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
05 يناير 2021 07:00:01 بحسب Nasdaq GlobeNewswire